Cronos Group Inc

Cronos Group Inc

CRON - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.35B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Cronos Group IncCronos Group Inc17.6-7%--
$5.22

Current Fair Value

48.8% upside

Undervalued by 48.8% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.35 Billion
Enterprise Value$890.25 Million
Earnings per Share$-0.03
Beta1.2
Outstanding Shares385,306,213

Return

Return on Equity6.53%ROE
Return on Assets5.91%
Return on Invested Capital4.35%

Valuation & Multiples

P/E Ratio17.65P/E Ratio
PEG-9.76PEG
Price to Sales-Price to Sales
Price to Book Ratio1.76Price to Book Ratio
Enterprise Value to Revenue3.49
Enterprise Value to EBIT18.21
Enterprise Value to Net Income12
Total Debt to Enterprise0.01
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 6, 2026
EPS Estimate
$0.01
Consensus analyst estimate
Revenue Estimate
$44.20 M
Consensus analyst estimate

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$0.03
Consensus analyst estimate
Revenue Estimate
$51.15 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 23.96%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.09%▼ 12.23%
Total Invested$1.29M▼ 99.04%
Investors Holding18▼ 188.00%

About Cronos Group Inc

610 employees
CEO: Michael Ryan Gorenstein

Cronos Group Inc. functions as a diversified global cannabinoid enterprise. Within the United States, it manufactures, promotes, and distributes a variety of hemp-derived supplements and cosmetic products. These items are available under...

Cronos Group Insider Information FAQ

Stockcircle tracks 4 top investors with a current 13F position in Cronos Group. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 1 top investor increased or opened positions and 2 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.